Fidgety Movements of Preterm Neonates Included in COSGOD III
Launched by MEDICAL UNIVERSITY OF GRAZ · Oct 23, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called COSGOD III, is studying the movements of preterm babies, specifically looking at "fidgety movements" that occur between six to 20 weeks after their expected due date. Researchers want to understand how certain medical care, including a technique called Near-Infrared Spectroscopy (NIRS), might help improve brain health and movement in these infants. By comparing the movements of babies who received this specialized care to those who did not, the study aims to find out if there are any differences in their short-term brain development outcomes.
To participate in this study, infants must have been part of the COSGOD III trial and undergone regular checks of their fidgety movements during the specified time frame. The trial is currently recruiting participants, and both boys and girls are eligible. Families can expect that their baby's movements will be closely observed to gather information about their development after being discharged from the hospital, which could help improve care for future preterm infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm neonates included in the COSGOD III trial
- • Death
- • Routinely performed fidgety movement (FM) analysis between six to 20 weeks post term
- Exclusion Criteria:
- • Neonates without FM analysis between six to 20 weeks post term
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, , Austria
Graz, , Austria
Patients applied
Trial Officials
Gerhard Pichler, Prof.
Principal Investigator
Division of Neonatology, Medical University of Graz, Austria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported